Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,252 | 56,902 | 90,168 | 14,324 | 22,203 |
| Other current assets | 2,878 | 3,976 | 3,613 | 1,178 | 69 |
| TOTAL | $24,130 | $60,878 | $93,781 | $15,502 | $22,272 |
| Non-Current Assets | |||||
| PPE Net | 29 | 43 | 35 | 13 | 38 |
| Investments And Advances | 236 | 9 | 495 | 0 | 200 |
| Intangibles | 2 | 6 | 10 | 0 | 3 |
| Other Non-Current Assets | 230 | 250 | 198 | 566 | 836 |
| TOTAL | $497 | $307 | $737 | $579 | $1,078 |
| Total Assets | $24,627 | $61,186 | $94,518 | $16,082 | $23,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,800 | 7,749 | N/A | 3,519 | N/A |
| Accounts payable and accrued liabilities | 11,000 | 15,110 | 5,935 | 6,600 | 5,119 |
| Other current liabilities | 88 | 90 | 223 | 267 | N/A |
| TOTAL | $13,115 | $23,164 | $6,357 | $10,658 | $5,383 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,799 | 29,656 | 30,857 | 15,183 | 17,632 |
| Other Non-Current Liabilities | 0 | 0 | 269 | 1,167 | 988 |
| TOTAL | $24,799 | $29,656 | $30,857 | $15,577 | $18,570 |
| Total Liabilities | $37,914 | $52,820 | $37,215 | $26,234 | $23,953 |
| Shareholders' Equity | |||||
| Common Shares | 63,932 | 63,020 | 63,020 | 61,826 | 61,367 |
| Retained earnings | -321,067 | -278,387 | -227,004 | -195,683 | -179,485 |
| Other shareholders' equity | 57 | -179 | -179 | 122 | 1,019 |
| TOTAL | $-13,287 | $8,365 | $57,304 | $-10,152 | $-603 |
| Total Liabilities And Equity | $24,627 | $61,186 | $94,518 | $16,082 | $23,350 |